“We continue to receive strong feedback in Europe for our Dual Energy THERMOCOOL SMARTTOUCH SF Catheter which we expect to launch in the U.S. later this year, having recently submitted a complete platform to FDA.”

How to check this claim

Look at: U.S. commercial launch status of the Dual Energy THERMOCOOL SMARTTOUCH SF Catheter

It came true if: Company confirms U.S. launch (FDA clearance and market availability) occurred on or before 2026-12-31

Where: Company press releases, FDA clearance database, and quarterly earnings call management commentary (Q3/Q4 2026)

Verify independently

SEC filings for JNJ ↗ · Claim quote is verbatim from the 2026Q1 earnings call.